Professionals 230 Users Online

Plasma Surgery Market

Rising Preference for Platelet Rich Plasma Therapies in Cosmetic Surgery is Driving the Plasma Surgery Market

Plasma Surgery Market by Product (Neutral Plasma Surgery System, Plasma Ablation Systems and Cold Plasma Surgical Systems)

Plasma Surgery Market Outlook (2023 to 2033)

The Global revenue from the Plasma Surgery Market was around US$ 64.5 Million in 2022, with the global market expected to grow at a CAGR of 5.4% to reach a valuation of around US$ 114.5 Million by the end of 2033.

Market Size (2023)

US$ 68.0 Million

Projected Market Value (2033)

US$ 114.5 Million

Global Market Growth Rate (2023 to 2033 )

5.4% CAGR

Market Share of Top 5 Countries

61.3%

As analysed by Persistence Market Research, plasma ablation systems held a market share of around 62.6% in the global market, in 2022. The global plasma surgery market holds nearly 0.2% revenue share of the global minimally invasive surgical devices market valued at US$ 25.8 Billion in 2022.

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Sales Analysis of Market from 2014 to 2022 Vs Market Outlook for 2023 to 2033

The global market recorded a historic CAGR of 4.7% in the last 8 years from 2014 to 2022.

The popularity of plasma therapy, which releases numerous growth factors from platelets by injecting a little amount of the patient's own blood, is on the rise. The use of cosmetic plasma operations has increased by 25% over the past four years, according to the American Society of Plastic Surgeons, which has been keeping track of the practise since 2015. Celebrities praising the procedure's aesthetic advantages may be a contributing factor for market rise.

The use of platelet-rich plasma (PRP) in the management of orthopaedic disorders, sports injuries, and musculoskeletal disorders has seen a surge in demand in recent years. It focuses on growth elements and can speed up healing significantly. PRP is an important source of modified products for each patient in the regenerative medicine, aiding the cascade of wound healing and tissue restoration.

The efficacy of plasma in different therapy contexts, such as the management of herniated discs and hair loss, is now the subject of several research investigations. Due to its growing availability and capacity to promote quicker healing, PRP has seen a significant increase in application across a variety of therapeutic fields. Although it cannot entirely replace some crucial traditional medications, this therapy can lower the financial expenditures of conventional medical procedures, thus raising demand.

The market growth of plasma procedures is being boosted by a number of benefits. It has been observed that tiny doses of cold plasma could kill cancer cells while sparing healthy ones. This opened up a different field of study known as "plasma oncology,”. Researchers all over the world revealed encouraging in vitro and in vivo outcomes on the elimination of several cancer cell lines through the low temperature plasma.

The global market is likely to show high growth over the coming years at a CAGR of 5.4% and reach a global market size of 114.5 Million by 2033.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

How Can the Global Market Grow?

Increase in the Use of Platelet Rich Plasma in Cosmetic Surgery and Wound Healing Surgery."

The contour of nose bulb and nostrils can be altered with the non-invasive skin tightening treatment known as plasma fibroblast. This technique works best on the nose when it comes to pore reduction, skin tone, and skin shaping. The most prevalent cosmetic operation for the face, with 352,555 patients in 2020, is nose reshaping, according to the statistics report published by the American Society of Plastic Surgeons.

The regenerative ability of platelet-rich plasma has been extensively documented in the research activities for years and has been used in multiple areas of plastic surgery. According to the American Society of Plastic Surgeons, more than 231,140 aesthetic surgeries were performed using platelet-rich plasma in 2020. As a result, the demand for plasma surgery is increasing.

Promising outcomes of plasma surgery include wound healing, bone formation in bisphosphonate-based osteonecrosis of the jaw, and soft tissue repair in the alveolar socket following dental surgery. Also, it is projected that medical variables would create a number of therapeutic expansion prospects, propelling the market in the future.

Growing healthcare spending offers hospitals and businesses substantial potential to increase revenue. The Organization for Economic Cooperation and Development (OECD) projected that by 2020, US$10 trillion has been spent on healthcare in the globe. In most European nations, healthcare spending is increasing more quickly than GDP (Gross domestic product).

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Can the Market Growth Be Affected in Any Way?

Complications in Electrosurgery and Potential Risk of Burns

The risk of flammable gases, such as anaesthetics or intestinal gas, interference of pacemakers and monitors, neuromuscular stimulation, including ventricular fibrillation, accidental burns, and infection transfer are some of the problems associated with electrosurgery.

Laparoscopic surgery electrosurgical device injury and damage is expected to occur 1–2 times per 1000 patients. Unrecognized intestinal injuries and significant vascular damage are a couple of these consequences. Unrecognized thermal injuries to the intestine during laparoscopic surgery are highly harmful and difficult to identify, making them particularly deadly with a significant related mortality. Vascular injuries, however, can be diagnosed through the appearance of unexpected bleeding. The safety association for plasma surgery has suffered due to the high number of burn cases and OR mishaps, which is expected to impede market growth.

Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

Country–wise Insights

Why is the United States Market Booming?

"Increasing Applications of PRP-based Treatments in Orthopaedic and Cosmetic Procedure.”

The United States accounted for around 38.0% market share in the global market in 2022.

The Statistics Report by American Society of Plastic Surgeons estimated that 15.6 million cosmetic procedures were performed in the United States in 2020, including 2.3 million cosmetic surgical procedures and 13.2 million minimally invasive procedures. Soft tissue filler with plasma and others, resurfacing, laser hair removal, and botox are examples of minimally invasive procedures. Aesthetic procedures, on the other hand, include nose reshaping, facelifts, eyelid surgery, and breast augmentations.

One in seven injuries suffered by high school athletes are knee injuries in the America, according to a 2019 article from the National Federation of State High School Associations. And it appears that the number of anterior cruciate ligament injuries is at an all-time high.

Treatment of sports injuries is one of PRP therapy's most frequently used applications. ACL (anterior cruciate ligament) injury patients receive a significant number of PRP treatments. Someone with an ACL injury will likely want to heal as quickly as possible because it can prevent an athlete or weekend warrior from participating in sports and fitness. Moreover, it is one of the ligaments that, when injured, cannot recover on its own, and hence, to accelerate the healing time, PRP treatments are in high demand in the country.

Owing to these trends, the market is expected to grow in the country.

Will the United Kingdom Be a Lucrative Market for Plasma Surgery?

"Adoption of Non-invasive Cosmetic Surgeries”

The United Kingdom market held around 6.9% share of the global market in 2022.

Non-surgical cosmetic procedures are increasingly being considered as part of the standard beauty or grooming regimen by 43% of United Kingdom people.

According to the British Association of Aesthetic Plastic Surgeons (BAAPS) audit, the top surgical procedures for both men and women in 2020 were total 15,405, with breast augmentation (4,010), breast reduction (3,395), liposuction (1,142), and abdominoplasty (1,410) being the most popular procedures nationwide.

The downtime for topical and injectable PRP cosmetic procedures is low to nonexistent. Most patients have an immediate, three-month improvement in texture and tone. The use of PRP in conjunction with plastic surgery will hasten the healing of scar tissue. Due to this function, plasma is frequently used in cosmetic procedures, which is what is driving the market in the nation.

How is China Emerging as a Prominent Market?

“Encouragement for Novel Oncology Treatments to Reduce Disease Burden”

China held a market share of about 6.0% of the global market in 2022.

The management of China's cancer burden and ensuring that patients obtain better, more equitable, and accessible treatment options depend on the acceleration of innovation in oncology in China. A flood of new oncology-focused biotech companies and higher standards in oncology research are two factors that are now driving China's advancement in oncology innovation.

The United States Food and Drug Administration has also given the green light for the first-ever application of cold atmospheric plasma technology in a clinical trial, which is currently the sole method for eliminating microscopic cancer tumours that are still present after surgery.

As a result, the market for plasma surgery is expanding in the nation as cold plasma therapies for cancer are used for oncological treatments.

Category–wise Insights

Which Product Type is More Adopted in the Global Market?

"Increased Usage of Plasma Ablation Technologies to Decrease Blood Loss During Surgical Procedures."

The plasma ablation systems held around 62.6% share of the total market in 2022.

During endoscopic excision of post-embolized stage I and II patients of JNA, plasma ablation is a useful approach to reduce blood loss and surgical time.

For instance, according to a study published in the International Journal of Pediatric Otorhinolaryngology in 2020, "plasma ablation-aided endoscopic excision versus conventional approach of endoscopic excision of adolescent nasopharyngeal angiofibroma," the use of plasma ablation reduced overall blood loss by 338 ml (mean difference), which was not statistically significant (p = 0.26). In patients who had embolization, the use of plasma ablation considerably reduced mean blood loss (648 ml, p = 0.046) and surgical time (83 min, p 0.001).

Which Application Holds Significant Market Share Globally?

“Plasma Tool Dissection Causes Less Bleeding, Less Tissue Damage, and Fewer Post-operative Infections.”

Dissection segment held around 49.5% share of the total market in 2022.

The use of the plasma dissection tool dramatically reduces the likelihood of postoperative infections. Another reason for this could be that the gadget produces significantly less smoke during the cut, which is toxic and has been shown to contain infectious organisms. Clinically, the least heat damage and the greatest collagen deposition permit, respectively, a faster tissue healing process and stronger wound resistance.

Thus, dissection of soft tissue for fewer postoperative issues is assisting in the segment leadership of the market.

Which End User is Widely Adopted?

“Hospital Infrastructure Development and Accessible Services"

Hospital held around 54.2% share of the total market in 2022. This is due to a quick uptake of PRP-based therapies in medical facilities due to the recent rise in osteoarthritis cases, increased demand for non-surgical management of therapy, and increasing rates of hair loss treatments in the hospitals.

Since plasma-based treatment produces positive outcomes in patients, doctors in hospitals are increasingly using plasma surgery, which promotes the market.

Competition Landscape

The key players leverage in a variety of organic and inorganic market expansion, such as new product launches and partnerships with major players and research institutes, to gain a competitive advantage.

Some key instances of development include:

  • EVA NEXUS, a highly reliable infusion system for cataract surgical treatment that enables doctors to operate at lower infusion pressures and keep a steady anterior chamber even in problematic cases, was introduced by Dutch Ophthalmic Research Center (International) BV in March 2022.
  • Alfa Instruments s.r.l. and Bausch + Lomb Company signed a distribution agreement in September 2022. The arrangement calls for Bausch + Lomb to market and distribute Alfa Instruments' Vitreocare line of surgical intraocular dyes wherever else besides Italy, where Alfa Instruments is headquartered.

Similarly, the team at Persistence Market Research has tracked recent developments related–companies in the Plasma Surgery market, which are available in the full report.

Plasma Surgery Industry Report Scope

Attribute

Details

Forecast Period

2023 to 2033

Historical Data Available for

2014 to 2022

Market Analysis

USD Million for Value

Key Countries Covered

  • United States
  • Canada
  • Brazil
  • Argentina
  • Mexico
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • BENELUX
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Türkiye
  • GCC Countries
  • North Africa
  • South Africa

Key Market Segments Covered

  • Product
  • Application
  • End User
  • Region

Key Companies Covered

  • Plasma surgical
  • Mechan Europe ltd
  • Bovie medical corporation (Apyx Medical Corporation)
  • Nova Plasma Ltd.
  • Royal Biologics
  • 4T Medical
  • Dutch Ophthalmic Research Center
  • Alfa Instruments

Report Coverage

  • Market Forecast
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Key Segments Covered in Plasma Surgery Industry Research

By Product:

  • Neutral Plasma Surgery System
  • Plasma Ablation Systems
  • Cold Plasma Surgical Systems

By Application:

  • Ablation
  • Resection
  • Dissection

End User

  • Speciality Clinics
  • Ambulatory Surgical Centers
  • Hospitals

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

- Companies Covered in This Report -

  • Medtronic Plc
  • Plasma surgical
  • Mechan Europe ltd
  • Bovie medical corporation (Apyx Medical Corporation)
  • Nova Plasma Ltd.
  • Royal Biologics
  • 4T Medical
  • Dutch Ophthalmic Research Center
  • Alfa Instruments

- Frequently Asked Questions -

The global market is currently valued at around US$ 64.5 Million in 2022.

Sales of the market are set to witness growth at a CAGR of 5.4% and be valued at around US$ 114.5 Million by 2033.

Demand for the global market increased at a 4.7% CAGR from 2014 to 2022.

The U.S., U.K., China, India, and Japan account for around 61.3% market share globally.

The U.S. accounts for around 38.0% share of the global market in 2022.

The China market held a share of about 6.0% in the global plasma surgery market in 2022.

U.K. plasma surgery market held at 6.9% share of the global market in 2022.

Key players in plasma surgery market are Plasma surgical, Mechan Europe ltd, Bovie medical corporation (Apyx Medical Corporation), Nova Plasma Ltd., Royal Biologics, 4T Medical, Dutch Ophthalmic Research Center, Alfa Instruments.

By product, plasma ablation systems dominated the global market in 2022. Plasma ablation systems held market share of around 62.6% in 2022 globally.

By application, ablation segment dominated the global market in 2022 and it held the market share of around 49.5% in 2022 globally.

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate